Telomir Pharmaceuticals, Inc. (TELO) income statement
TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.36−0.08 (-17.24%)
Close on Nov 20, 2026Market cap $25.03MP/E –Yield –
Telomir Pharmaceuticals, Inc. financial ratios
See a number that looks wrong?